Transcarent and accolade announce expiration of hart-scott rodino waiting period for pending merger transaction

San francisco and seattle, feb. 24, 2025 (globe newswire) -- transcarent, the one place for health and care, and accolade (nasdaq:accd), a leader in health advocacy, expert medical opinions, and primary care, today announced the expiration of the waiting period under the hart-scott-rodino (“hsr”) antitrust improvements act of 1976 with respect to the previously announced merger between the two companies.
ACCD Ratings Summary
ACCD Quant Ranking